Related Experiment Video
Updated: Jun 7, 2025

10:49
Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
Published on: September 18, 2013
18.1K
Symptom Screening for Hospitalized Pediatric Patients With Cancer: A Randomized Clinical Trial.
L Lee Dupuis1,2,3, Donna L Johnston4, David Dix5
1Program in Child Health Evaluative Sciences, Peter Gilgan Centre for Research and Learning, The Hospital for Sick Children, Toronto, Ontario, Canada.
JAMA Pediatrics
|November 13, 2024
Summary
Daily symptom screening using the Symptom Screening in Pediatrics Tool (SSPedi) significantly reduced symptom burden in pediatric cancer patients. This approach improved total symptom scores compared to standard care, enhancing patient treatment experiences.
Area of Science:
- Oncology
- Clinical Trials
- Pediatric Healthcare
Background:
- Pediatric cancer patients often experience severe symptoms during treatment.
- Effective symptom management is crucial for improving quality of life in these patients.
Purpose of the Study:
- To evaluate if daily symptom screening and reporting via the Symptom Screening in Pediatrics Tool (SSPedi) reduces symptom burden in pediatric cancer patients.
- To compare the effectiveness of daily symptom screening against usual care in a hospital or clinic setting.
Main Methods:
- A randomized clinical trial involving pediatric cancer patients (aged 8-18) requiring daily hospital or clinic visits for at least 5 days.
- Participants were assigned to either daily SSPedi screening with reports to the healthcare team or usual care.
- Data analysis included comparing day 5 total SSPedi scores using multiple linear regression and analyzing secondary outcomes with proportional odds models.
Main Results:
- Daily symptom screening significantly improved total symptom burden scores on day 5 compared to usual care (adjusted mean difference: -2.5).
- Symptom screening reduced the likelihood of higher individual symptom scores, with 8 of 15 symptoms showing statistically significant reductions.
- While pain and quality of life scores did not differ significantly, symptom documentation and intervention rates increased with the screening protocol.
Conclusions:
- Daily symptom screening using the SSPedi tool is effective in reducing overall symptom burden for pediatric cancer patients.
- This intervention improves symptom management and documentation, contributing to better patient care during treatment.
- The findings support the integration of systematic symptom screening into routine care for pediatric oncology patients.
Related Concept Videos
Cancer Survival Analysis
328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328
Hazard Ratio
91
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
91

